Labiana Health SA
MAD:LAB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Labiana Health SA
MAD:LAB
|
ES |
|
T
|
TQR PCL
SET:TQR
|
TH |
|
Objective Corporation Ltd
ASX:OCL
|
AU |
|
T
|
Turbon AG
F:TUR
|
DE |
|
O
|
Okong Corp
KOSDAQ:045060
|
KR |
Wall Street
Price Targets
LAB Price Targets Summary
Labiana Health SA
According to Wall Street analysts, the average 1-year price target for LAB is 7.01 EUR with a low forecast of 6.94 EUR and a high forecast of 7.21 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is LAB's stock price target?
Price Target
7.01
EUR
According to Wall Street analysts, the average 1-year price target for LAB is 7.01 EUR with a low forecast of 6.94 EUR and a high forecast of 7.21 EUR.
What is Labiana Health SA's Revenue forecast?
Projected CAGR
11%
For the last 5 years the compound annual growth rate for Labiana Health SA's revenue is 6%. The projected CAGR for the next 3 years is 11%.
What is Labiana Health SA's Operating Income forecast?
Projected CAGR
31%
For the last 5 years the compound annual growth rate for Labiana Health SA's operating income is 30%. The projected CAGR for the next 3 years is 31%.
What is Labiana Health SA's Net Income forecast?
Projected CAGR
219%
For the last 5 years the compound annual growth rate for Labiana Health SA's net income is -17%. The projected CAGR for the next 3 years is 219%.
